Andrew Adam, MS

PhD Candidate
University of Miami School of Medicine - Miami, FL, United States

Presentation(s):

• 46: A novel mechanism of immunotherapy sensitivity following platinum chemotherapy resistance in pancreatic cancer patients with germline homologous recombination deficiency

  Thursday, March 21, 2024
  2:42pm – 2:52pm ET

• 56: Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer

  Saturday, March 23, 2024
  9:02am – 9:12am ET